OOIR: Observatory of International Research

Papers

(The H4-Index of Critical Reviews in Clinical Laboratory Sciences is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Data analytics for error detection in clinical laboratories	69
Lipoprotein(a): a genetically determined risk factor for Cardiovascular disease	62
The dual roles of microorganisms in inflammatory diseases: initiators and regulators	55
Aptamer-based biosensing strategies for influenza virus detection: a systematic and critical review of electrochemical and optical platforms	52
The anion gap as a predictive tool for morbidity and mortality	52
Deep learning algorithms and Raman spectroscopy in the clinical laboratory setting	39
Advances and challenges in the measurement of 1,25-dihydroxyvitamin D: a comprehensive review	38
Machine learning-based error detection in the clinical laboratory: a critical review	35
Human telomere length detected by quantitative fluorescent in situ hybridization: overlooked importance and application	34
Single cell mechanodeformation signatures as early biomarkers for hematological malignancies	33
Copeptin as a surrogate marker for arginine vasopressin: analytical insights, current utility, and emerging applications	30
Transthyretin mutagenesis: impact on amyloidogenesis and disease	28
Clinical utility of human epididymis protein 4	27
Comparison of liquid biopsy-based technologies for cancer screening	26
The therapeutic relevance of the Kallikrein-Kinin axis in SARS-cov-2-induced vascular pathology	26
Beyond newborn screening: the role of reverse cascade testing in familial disease detection	24
Cardiovascular disease lipids and lipoproteins biomarker standardization	23
Indirect methods for the verification of reference intervals in laboratory medicine	23
Guidance for securing approvals for new biomarkers: from discovery to clinical implementation	23
Mid-regional pro-atrial natriuretic peptide in managing cardiovascular and cerebrovascular diseases	22
KIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker	22
Development of next-generation reference interval models to establish reference intervals based on medical data: current status, algorithms and future consideration	21
One health and laboratory medicine: challenges and perspectives for antimicrobial resistance, emerging infections, and food/water security	21